GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 18-005_006 Universitair Medisch Centrum Utrecht Clinical development program for a gene replacement therapy for patients with Spinal Muscular Atrophy utilizing AVXS-101, an adeno-associated viral vector serotype 2/9 containing the human SMN gene. 31-05-2022 Vergunning verleend
IM-MV 18-010_006 Prinses Máxima Centrum Testing the safety and efficacy of JCAR017 in patients with aggressive B cell malignancies 15-06-2022 Vergunning verleend
IM-MV 20-010_003 Erasmus MC MVA-MERS-S_DF1: An MVA-vectored vaccine candidate against MERS coronavirus, encoding the MERS spike protein 19-07-2022 Vergunning verleend
IM-MV 21-011_000 AMC AAV clinical vectors with a target nuclease as insert, used in vivo, to treat and/or prevent disease Ontwerpbesluit genomen